| Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
|---|
| 03/20/2002 | EP1187827A1 Antiviral agents |
| 03/20/2002 | EP0944590B1 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/20/2002 | CN1341124A Anti-CD3 immunotoxins and therapeutic use thereof |
| 03/20/2002 | CN1341106A Process crystallising N-(4-trifluoromethylphenyl)-5-methyl-isoxazole-4-carboxamide |
| 03/19/2002 | US6359143 Heterocycle-bearing thio phenol compounds, intermediates for the preparation of the same and processes for the preparation of both |
| 03/19/2002 | US6358983 Heterocyclically substituted α-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonists |
| 03/19/2002 | CA2079548C Carbamate derivatives of 4-amino-3- isoxazolidinones, 3-amino-1- hydroxypyrrolidin-2-ones and 1-amino-1- cyclopropanecarboxylic acid analogs, a process for their preparation and their use as medicaments |
| 03/14/2002 | WO2001070673A3 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a) |
| 03/14/2002 | US20020032237 Antipicornaviral compounds, compositions containing them, and methods for their use |
| 03/14/2002 | US20020032227 Oxime derivative and bactericide containing the same as active ingredient |
| 03/14/2002 | DE10043075A1 Heterocyclyl-substituierte Benzoylcyclohexandione, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide Heterocyclyl-substituted benzoylcyclohexanediones, process for their preparation and their use as herbicides |
| 03/12/2002 | US6355807 Multistep process including cyanomethylation, reduction, cyclization, deprotection, oxidation, olefination and amidation |
| 03/12/2002 | US6355796 Reacting beta-amino-beta-(perfluoroalkyl)acrylate compound with base and carbamoyl chloride compound to form urea compound, reacting urea compound with phosphorus pentahalide or oxalyl halide |
| 03/12/2002 | US6355673 Substituted diaminocarboxylic acids |
| 03/12/2002 | US6355662 Peptide and nonpeptides autoimmune diseases, antiinflammatory agents |
| 03/07/2002 | WO2002018352A1 Heterocyclically substituted benzoylcyclohexanediones, methods for producing them and their use as herbicides |
| 03/07/2002 | WO2002017923A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 03/07/2002 | WO2002017712A2 Disubstituted benzenes as insecticides |
| 03/07/2002 | WO2001068033A3 Il-8 receptor antagonists |
| 03/07/2002 | US20020028834 Heterocyclic-cyclic amine derivatives |
| 03/07/2002 | US20020028774 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/07/2002 | CA2420804A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 03/06/2002 | EP1183233A2 Bradykinin receptor antagonists |
| 03/06/2002 | EP1183232A2 Monofluoroalkyl derivatives |
| 03/06/2002 | EP1183019A2 Ace-2 inhibiting compounds and methods of use thereof |
| 03/05/2002 | CA2206122C Arylacrylamide derivatives |
| 02/28/2002 | WO2002016311A1 Carboxylic acid derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 02/28/2002 | WO2002016305A1 METHOD FOR PRODUCING β KETOENOL ESTERS |
| 02/28/2002 | WO2002015884A2 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
| 02/28/2002 | WO2001046200A8 Novel piperidine and piperazine derivatives |
| 02/28/2002 | US20020026060 RAR selective retinoid agonists |
| 02/28/2002 | US20020025963 Novel guanidine mimics as factor Xa inhibitors |
| 02/28/2002 | US20020025910 3-heterocycly1 - substituted benzoyl derivatives |
| 02/28/2002 | CA2419592A1 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
| 02/26/2002 | US6350749 Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof |
| 02/21/2002 | WO2002014267A1 Novel aminocyclohexane derivatives |
| 02/21/2002 | WO2002013822A1 Micronized leflunomide |
| 02/21/2002 | WO2001081328A3 Thiazolidinedione analogues and their use for the treatment of diabetes |
| 02/21/2002 | WO2001072960A3 Il-8 receptor antagonists |
| 02/21/2002 | US20020022724 Organic initiators and their use in the polymerization of unsaturated monomers |
| 02/21/2002 | US20020022646 Method for systhesizing leflunomide |
| 02/21/2002 | US20020022623 A substituted hydroxyethylene compound useful for treating Alzheimer's disease, mild cognitive impairment, Down's syndrome, herediatary cerebral hemmorrhage with amyloidosis, degenerative dementia |
| 02/19/2002 | CA2025939C Carboxamides of isoxazole- and isothiazole-carboxylic acids |
| 02/14/2002 | US20020019412 Antidiabetic agents |
| 02/14/2002 | US20020019403 Inhibit amyloid protein deposits |
| 02/13/2002 | EP1178987A1 Substituted benzoylisoxazoles and the use thereof as herbicides |
| 02/12/2002 | US6346517 Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders |
| 02/07/2002 | US20020016461 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 02/07/2002 | US20020016361 Beta-amino acid nitrile derivatives as cathepsin K inhibitors |
| 02/07/2002 | US20020016342 Combination therapy using COX-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 02/07/2002 | US20020016336 Treatment of rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration, tumor metastasis or invasion, periodontal disease and bone disease |
| 02/07/2002 | US20020016323 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| 02/06/2002 | EP1177193A1 Process for the preparation of 6-(perfluoroalkyl)uracil compounds |
| 02/06/2002 | EP1177176A1 Tri-aryl acid derivatives as ppar receptor ligands |
| 02/06/2002 | CN1334801A Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 02/06/2002 | CN1334798A Phenylglycine derivatives |
| 02/06/2002 | CN1334726A Hydroxy diphenyl urea sulfonamides as IL-8 receptor antagonists |
| 02/05/2002 | US6344471 Diisopropyl fluorophosphate (dfp), treatment of cognitive disorders, depression, schizophrenia and anxiety. |
| 02/05/2002 | CA2123403C Acyclic ethylenediamine derivatives as substance p receptor antagonists |
| 01/31/2002 | US20020013357 Valdecoxib compositions |
| 01/30/2002 | EP1175214A2 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 01/30/2002 | EP0907634B1 Pesticides |
| 01/30/2002 | CN1333769A Thiourea inhibitors of herps viruses |
| 01/30/2002 | CN1333750A Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
| 01/29/2002 | US6342610 Compounds such as n-(4-bromo-3-methyl-5-isoxazolyl)-2-n-benzylbenzo(b)thiophene-3-sufonamide administered as endothelin peptide receptor antagonists |
| 01/29/2002 | US6342513 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| 01/24/2002 | WO2002006276A1 Beta3 adrenergic agonists |
| 01/24/2002 | WO2002006213A2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 01/24/2002 | WO2002006211A1 Preparation of 4-thioalkylbromobenzene derivatives |
| 01/24/2002 | WO2002006189A2 Aniline derivatives |
| 01/24/2002 | WO2002005848A2 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| 01/24/2002 | WO2002005815A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug |
| 01/24/2002 | WO2000053168A3 Synergy between low molecular weight heparin and platelet aggregation inhibitors, for preventing and treating thromboembolic disorders |
| 01/24/2002 | WO2000045799A3 Use of substituted isoxazol carboxylic acids and derivatives and novel substances |
| 01/24/2002 | US20020010343 Compounds having IgE affecting properties |
| 01/24/2002 | CA2416722A1 Preparation of 4-thioalkylbromobenzene derivatives |
| 01/24/2002 | CA2415331A1 Beta3 adrenergic agonists |
| 01/24/2002 | CA2414780A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug |
| 01/24/2002 | CA2414674A1 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| 01/23/2002 | EP1174429A1 Process for the preparation of (e)-3-(1-propenyl)isoxazoline |
| 01/23/2002 | EP1173183A2 Use of compounds with a nitrogen-oxygen heterocycle |
| 01/23/2002 | CN1078202C Method of preparing essentially pure isomers of alpha-bis-oximes |
| 01/22/2002 | CA2024956C Isoxazoles herbicides |
| 01/17/2002 | WO2002004407A2 7-substituted tetracycline compounds |
| 01/17/2002 | US20020006951 Solid-state form of celecoxib having enhanced bioavailability |
| 01/17/2002 | US20020006945 Immunology diseases |
| 01/17/2002 | DE10032874A1 New 4-substituted 3,5-dialkyl-isoxazole derivatives, useful as antiviral agents having strong activity against hepatitis B virus and low cytotoxicity |
| 01/16/2002 | EP1171427A1 Process for the preparation of 6-(perfluoroalkyl) uracil compounds from urea compounds |
| 01/16/2002 | EP0882028B1 New intermediates to pesticides |
| 01/15/2002 | US6339099 Guanidine mimics as factor Xa inhibitors |
| 01/10/2002 | WO2002002593A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 01/10/2002 | WO2002002555A1 Novel isoxazolinone antibacterial agents |
| 01/10/2002 | WO2002002537A1 Method for producing 4-bromine-aniline derivatives |
| 01/10/2002 | WO2002002512A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | CA2410651A1 Compounds to treat alzheimer's disease |
| 01/09/2002 | EP1169312A2 Glucokinase activators |
| 01/09/2002 | EP1169308A1 Processes and intermediates for the preparation of 1,3-oxazin-6-ones and uracils |
| 01/09/2002 | CN1330631A Amide derivatives which are useful as cell factor inhibitors |
| 01/09/2002 | CN1329827A 3-hydroxy-5-methyl-isoxazole pesticide composition and using method |
| 01/03/2002 | WO2002000651A2 Factor xa inhibitors |